<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:12:28Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9928676" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9928676</identifier>
        <datestamp>2023-02-15</datestamp>
        <setSpec>pheelsevier</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Pharmacol Res</journal-id>
              <journal-id journal-id-type="iso-abbrev">Pharmacol Res</journal-id>
              <journal-title-group>
                <journal-title>Pharmacological Research</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1043-6618</issn>
              <issn pub-type="epub">1096-1186</issn>
              <publisher>
                <publisher-name>The Author(s). Published by Elsevier Ltd.</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9928676</article-id>
              <article-id pub-id-type="pmcid">PMC9928676</article-id>
              <article-id pub-id-type="pmc-uid">9928676</article-id>
              <article-id pub-id-type="pmid">36804278</article-id>
              <article-id pub-id-type="pii">S1043-6618(23)00058-0</article-id>
              <article-id pub-id-type="doi">10.1016/j.phrs.2023.106702</article-id>
              <article-id pub-id-type="publisher-id">106702</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Beneficial effects of <sc>L</sc>-Arginine in patients hospitalized for COVID-19: New insights from a randomized clinical trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" id="au0005">
                  <name>
                    <surname>Trimarco</surname>
                    <given-names>Valentina</given-names>
                  </name>
                  <xref rid="aff0005" ref-type="aff">a</xref>
                  <xref rid="fn1" ref-type="fn">1</xref>
                </contrib>
                <contrib contrib-type="author" id="au0010">
                  <name>
                    <surname>Izzo</surname>
                    <given-names>Raffaele</given-names>
                  </name>
                  <xref rid="aff0010" ref-type="aff">b</xref>
                  <xref rid="fn1" ref-type="fn">1</xref>
                </contrib>
                <contrib contrib-type="author" id="au0015">
                  <name>
                    <surname>Lombardi</surname>
                    <given-names>Angela</given-names>
                  </name>
                  <xref rid="aff0015" ref-type="aff">c</xref>
                </contrib>
                <contrib contrib-type="author" id="au0020">
                  <name>
                    <surname>Coppola</surname>
                    <given-names>Antonietta</given-names>
                  </name>
                  <xref rid="aff0020" ref-type="aff">d</xref>
                </contrib>
                <contrib contrib-type="author" id="au0025">
                  <name>
                    <surname>Fiorentino</surname>
                    <given-names>Giuseppe</given-names>
                  </name>
                  <xref rid="aff0020" ref-type="aff">d</xref>
                </contrib>
                <contrib contrib-type="author" id="au0030">
                  <name>
                    <surname>Santulli</surname>
                    <given-names>Gaetano</given-names>
                  </name>
                  <xref rid="aff0010" ref-type="aff">b</xref>
                  <xref rid="aff0015" ref-type="aff">c</xref>
                  <xref rid="aff0025" ref-type="aff">e</xref>
                  <xref rid="cor1" ref-type="corresp">⁎</xref>
                </contrib>
                <aff id="aff0005"><label>a</label>Department of Neuroscience, Reproductive Sciences and Dentistry, “Federico II” University, Naples, Italy</aff>
                <aff id="aff0010"><label>b</label>Department of Advanced Biomedical Sciences, “Federico II” University, Naples, Italy</aff>
                <aff id="aff0015"><label>c</label>Department of Medicine, Albert Einstein College of Medicine – Montefiore University Hospital, New York, NY, United States of America</aff>
                <aff id="aff0020"><label>d</label>COVID-19 Division, A.O.R.N. “Ospedali dei Colli”, Naples, Italy</aff>
                <aff id="aff0025"><label>e</label>Department of Molecular Pharmacology, Albert Einstein College of Medicine – New York, NY, United States of America</aff>
              </contrib-group>
              <author-notes>
                <corresp id="cor1"><label>⁎</label>Correspondence to: Albert Einstein College of Medicine – Montefiore University Hospital, 1300 Morris PARK AVENUE, Suite G35, New York City, NY, United States of America.</corresp>
                <fn id="fn1">
                  <label>1</label>
                  <p id="ntp0005">Equally contributed.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="pmc-release">
                <day>15</day>
                <month>2</month>
                <year>2023</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
              <pub-date pub-type="ppub">
                <month>5</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>15</day>
                <month>2</month>
                <year>2023</year>
              </pub-date>
              <volume>191</volume>
              <fpage>106702</fpage>
              <lpage>106702</lpage>
              <history>
                <date date-type="received">
                  <day>24</day>
                  <month>1</month>
                  <year>2023</year>
                </date>
                <date date-type="rev-recd">
                  <day>3</day>
                  <month>2</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>14</day>
                  <month>2</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2023 The Authors</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license>
                  <license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p>
                </license>
              </permissions>
              <abstract id="ab0010">
                <p>We have recently demonstrated in a double-blind randomized trial the beneficial effects of <sc>L</sc>-Arginine in patients hospitalized for COVID-19. We hypothesize that one of the mechanisms underlying the favorable effects of <sc>L</sc>-Arginine is its action on inflammatory cytokines. To verify our hypothesis, we measured longitudinal plasma levels of pro-inflammatory and anti-inflammatory cytokines implied in the pathophysiology of COVID-19 in patients randomized to receive oral <sc>L</sc>-Arginine or placebo. The study was successfully completed by 169 patients. Patients in the <sc>L</sc>-Arginine arm had a reduced respiratory support evaluated at 10 and 20 days; moreover, the time to hospital discharge was significantly shorter in the <sc>L</sc>-Arginine group. The assessment of circulating cytokines revealed that <sc>L</sc>-Arginine significantly reduced the circulating levels of pro-inflammatory IL-2, IL-6, and IFN-γ and increased the levels of the anti-inflammatory IL-10. Taken together, these findings indicate that adding <sc>L</sc>-Arginine to standard therapy in COVID-19 patients markedly reduces the need of respiratory support and the duration of in-hospital stay; moreover, <sc>L</sc>-Arginine significantly regulates circulating levels of pro-inflammatory and anti-inflammatory cytokines.</p>
              </abstract>
              <abstract abstract-type="graphical" id="ab0015">
                <title>Graphical Abstract</title>
                <p>
                  <fig id="fig0020" position="anchor">
                    <alt-text id="at0025">ga1</alt-text>
                    <graphic xlink:href="ga1_lrg"/>
                  </fig>
                </p>
              </abstract>
              <kwd-group id="keys0005">
                <title>Keywords</title>
                <kwd>Arginine</kwd>
                <kwd>COVID-19</kwd>
                <kwd>Critical Care</kwd>
                <kwd>Cytokine storm</kwd>
                <kwd>Inflammation</kwd>
                <kwd>IL-6</kwd>
                <kwd>IL-2</kwd>
                <kwd>IFN-γ</kwd>
                <kwd>IL-10</kwd>
                <kwd>Lymphocytes</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="sec0005">
              <label>1</label>
              <title>Introduction</title>
              <p id="p0005">We and others have demonstrated that endothelial dysfunction contributes to coronavirus disease (COVID-19)-associated acute respiratory distress syndrome <xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>, <xref rid="bib3" ref-type="bibr">[3]</xref>, <xref rid="bib4" ref-type="bibr">[4]</xref>, <xref rid="bib5" ref-type="bibr">[5]</xref>, <xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib8" ref-type="bibr">[8]</xref>, <xref rid="bib9" ref-type="bibr">[9]</xref>, <xref rid="bib10" ref-type="bibr">[10]</xref>, <xref rid="bib11" ref-type="bibr">[11]</xref>, <xref rid="bib12" ref-type="bibr">[12]</xref>, <xref rid="bib13" ref-type="bibr">[13]</xref>, <xref rid="bib14" ref-type="bibr">[14]</xref>, <xref rid="bib15" ref-type="bibr">[15]</xref>.</p>
              <p id="p0010">The amino acid <sc>L</sc>-Arginine has been previously shown to improve endothelial function <xref rid="bib16" ref-type="bibr">[16]</xref>, <xref rid="bib17" ref-type="bibr">[17]</xref>, <xref rid="bib18" ref-type="bibr">[18]</xref>, <xref rid="bib19" ref-type="bibr">[19]</xref>, <xref rid="bib20" ref-type="bibr">[20]</xref>. Specifically, in a double-blind randomized, placebo-controlled trial, we have recently established the beneficial effects of adding oral <sc>L</sc>-Arginine to hospital standard-therapy in patients hospitalized for COVID-19 <bold>(</bold>
<ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04637906" id="ir0005">NCT04637906</ext-link>
<bold>)</bold>
<xref rid="bib21" ref-type="bibr">[21]</xref>; however, the exact mechanisms have not been explored.</p>
              <p id="p0015">Based on reports showing anti-inflammatory effects of <sc>L</sc>-Arginine <italic>in vitro</italic>
<xref rid="bib22" ref-type="bibr">[22]</xref>, <xref rid="bib23" ref-type="bibr">[23]</xref> and in preclinical models <xref rid="bib24" ref-type="bibr">[24]</xref>, we hypothesized that one of the mechanisms underlying the favorable effects of <sc>L</sc>-Arginine, alongside the known improvement of endothelial dysfunction <xref rid="bib25" ref-type="bibr">[25]</xref>, could be its action on the circulating levels of inflammatory cytokines.</p>
            </sec>
            <sec id="sec0010">
              <label>2</label>
              <title>Methods</title>
              <sec id="sec0015">
                <label>2.1</label>
                <title>Study design and procedures</title>
                <p id="p0020">Details on the study design, inclusion and exclusion criteria, procedures, outcomes to be assessed, and statistical analyses have been reported in the published protocol <xref rid="bib21" ref-type="bibr">[21]</xref>.</p>
              </sec>
              <sec id="sec0020">
                <label>2.2</label>
                <title>Ethical approval</title>
                <p id="p0025">The Study was approved by the institutional Ethical Committee (A.O.R.N. “Ospedali dei Colli”, Naples, Italy); written informed consent was collected from all patients, or their legal representative if they were unable to provide consent. The trial was performed in accordance with the principles of the Declaration of Helsinki and the International Conference on Harmonization-Good Clinical Practice guidelines.</p>
              </sec>
              <sec id="sec0025">
                <label>2.3</label>
                <title>Cytokine measurements</title>
                <p id="p0030">We assessed longitudinal plasma levels of IFN-γ, IL-2, IL-6, and IL-10, which have been implied in the pathophysiology of COVID-19 <xref rid="bib26" ref-type="bibr">[26]</xref>, <xref rid="bib27" ref-type="bibr">[27]</xref>, <xref rid="bib28" ref-type="bibr">[28]</xref>, <xref rid="bib29" ref-type="bibr">[29]</xref>, <xref rid="bib30" ref-type="bibr">[30]</xref>. Circulating levels of cytokines were measured on hospital admission and after 2 weeks, through ELISA, as previously described <xref rid="bib29" ref-type="bibr">[29]</xref>. Details on the study design, inclusion and exclusion criteria, procedures, outcomes to be assessed, and statistical analyses have been reported in the published trial <xref rid="bib21" ref-type="bibr">[21]</xref>.</p>
              </sec>
              <sec id="sec0030">
                <label>2.4</label>
                <title>Statistical analyses</title>
                <p id="p0035">Data were analyzed by <italic>SPSS</italic> (version 26.0; SPSS, IBM, Armonk, USA) and by the open software <italic>jamovi</italic> (version 2.3.16.0) and expressed as mean±SD or numbers and percentage, as appropriate. Differences in cytokine expression were assessed <italic>via</italic> ANOVA followed by Tukey <italic>post hoc</italic> correction. The null hypothesis was rejected at a two-tailed p &lt; 0.05.</p>
              </sec>
            </sec>
            <sec id="sec0035">
              <label>3</label>
              <title>Results</title>
              <p id="p0040">A total of 169 patients successfully completed the study (please see the flowchart shown in
<xref rid="fig0005" ref-type="fig">Fig. 1</xref>): 84 randomized to receive placebo, 85 to <sc>L</sc>-Arginine. A 100 % protocol adherence was achieved. All patients were randomized and received the assigned treatments with a mean of 7.8 days after symptoms onset. The main characteristics of the patients are shown in
<xref rid="tbl0005" ref-type="table">Table 1</xref>.<fig id="fig0005"><label>Fig. 1</label><caption><p>Flowchart of the study.</p></caption><alt-text id="at0005">Fig. 1</alt-text><graphic xlink:href="gr1_lrg"/></fig><table-wrap position="float" id="tbl0005"><label>Table 1</label><caption><p>Main characteristics of the two study groups. Data are presented as means ± SD for continuous variables; percentages are reported for categorical variables. ALT: Alanine aminotransferase; AST: aspartate aminotransferase; BUN: blood urea nitrogen; CPAP: continuous positive airway pressure; CRP: C Reactive Protein; HFNC: high-flow nasal cannula; LMWH: low molecular weight heparin; LTOT: long-term oxygen therapy; NIV: non-invasive ventilation.</p></caption><alt-text id="at0020">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th/><th>Placebo<break/>(n = 84)</th><th><sc>L</sc>-Arginine<break/>(n = 85)</th><th>p</th></tr></thead><tbody><tr><td><bold>Gender (M/F, %)</bold></td><td>75.3/34.7</td><td>64.7/35.3</td><td align="char">0.137</td></tr><tr><td><bold>Age (years)</bold></td><td>62.0 ± 11.9</td><td>61.1 ± 13.2</td><td align="char">0.634</td></tr><tr><td><bold>Hypertension (%)</bold></td><td>46.9</td><td>37.6</td><td align="char">0.227</td></tr><tr><td><bold>Coronary artery disease (%)</bold></td><td>14.8</td><td>17.6</td><td align="char">0.621</td></tr><tr><td><bold>Smokers (%)</bold></td><td>13.6</td><td>11.8</td><td align="char">0.725</td></tr><tr><td><bold>Obesity (%</bold></td><td>9.9</td><td>10.6</td><td align="char">0.880</td></tr><tr><td><bold>Diabetes (%)</bold></td><td>11.1</td><td>11.8</td><td align="char">0.895</td></tr><tr><td><bold>Time between onset of symptoms and admission (days)</bold></td><td>7.9 ± 3.1</td><td>7.9 ± 3.3</td><td align="char">0.982</td></tr><tr><td><bold>White blood cells (n/mL)</bold></td><td>8521.4 ± 5103.6</td><td>7709.4 ± 4222.2</td><td align="char">0.265</td></tr><tr><td><bold>Lymphocytes (n/mL)</bold></td><td>796.8 ± 362.4</td><td>782.1 ± 329.4</td><td align="char">0.788</td></tr><tr><td><bold>CRP (mg/L)</bold></td><td>8.0 ± 6.7</td><td>11.1 ± 10.4</td><td align="char">0.029</td></tr><tr><td><bold><sc>D</sc>-dimer (ng/mL)</bold></td><td>945.5 ± 1660.6</td><td>709.7 ± 1157.2</td><td align="char">0.295</td></tr><tr><td><bold>ALT (U/L</bold></td><td>62.9 ± 82.7</td><td>53.2 ± 44.5</td><td align="char">0.351</td></tr><tr><td><bold>AST (U/L)</bold></td><td>46.3 ± 40.1</td><td>40.8 ± 29.0</td><td align="char">0.312</td></tr><tr><td><bold>Creatinine (mg/dL)</bold></td><td>0.89 ± 0.7</td><td>0.78 ± 0.2</td><td align="char">0.100</td></tr><tr><td><bold>Sodium (mmol/L)</bold></td><td>138.5 ± 4.1</td><td>138.5 ± 4.6</td><td align="char">0.946</td></tr><tr><td><bold>Potassium (mmol/L)</bold></td><td>4.44 ± 0.7</td><td>4.40 ± 0.5</td><td align="char">0.690</td></tr><tr><td><bold>Asthenia (%)</bold></td><td>63.0</td><td>63.5</td><td align="char">0.940</td></tr><tr><td><bold>Dyspnea (%)</bold></td><td>91.4</td><td>89.4</td><td align="char">0.671</td></tr><tr><td><bold>Cough (%)</bold></td><td>37.0</td><td>32.9</td><td align="char">0.580</td></tr><tr><td><bold>Fever (%)</bold></td><td>67.9</td><td>75.3</td><td align="char">0.291</td></tr><tr><td><bold>Sputum (%)</bold></td><td>8.6</td><td>2.4</td><td align="char">0.074</td></tr><tr><td><bold>Remdesivir (%)</bold></td><td>39.5</td><td>44.7</td><td align="char">0.498</td></tr><tr><td><bold>LMWH (%)</bold></td><td>95.1</td><td>92.9</td><td align="char">0.566</td></tr><tr><td><bold>Steroids (%)</bold></td><td>86.4</td><td>92.9</td><td align="char">0.166</td></tr><tr><td><bold>Monoclonal antibodies (%)</bold></td><td>15.4</td><td>10.0</td><td align="char">0.472</td></tr><tr><td><bold>Anti-COVID vaccine (%)</bold></td><td>45.7</td><td>47.1</td><td align="char">0.859</td></tr><tr><td><bold>P/F (PaO</bold><sub><bold>2</bold></sub><bold>/FiO</bold><sub><bold>2</bold></sub><bold>- baseline)</bold></td><td>132.0 ± 57.5</td><td>148.6 ± 66.1</td><td align="char">0.086</td></tr><tr><td><bold>P/F (PaO</bold><sub><bold>2</bold></sub><bold>/FiO</bold><sub><bold>2</bold></sub><bold>- day 10)</bold></td><td>190.5 ± 116.3</td><td>216.8 ± 96.0</td><td align="char">0.281</td></tr><tr><td><bold>P/F (PaO</bold><sub><bold>2</bold></sub><bold>/FiO</bold><sub><bold>2</bold></sub><bold>- day 20)</bold></td><td>255.5 ± 103.4</td><td>258.8 ± 89.0</td><td align="char">0.857</td></tr><tr><td><bold>Hospitalization (days)</bold></td><td>35.9 ± 15.4</td><td>21.9 ± 7.7</td><td align="char">0.0001</td></tr><tr><td><bold>Death</bold></td><td>13 (13.8%)</td><td>3 (3.4%)</td><td align="char">0.013</td></tr><tr><td colspan="4"><bold>Respiratory support (baseline)</bold></td></tr><tr><td><bold>None (%)</bold></td><td>1.2</td><td>0</td><td align="char" rowspan="5">0.500</td></tr><tr><td><bold>LTOT (%)</bold></td><td>3.7</td><td>9.4</td></tr><tr><td><bold>HFNC (%)</bold></td><td>77.8</td><td>71.8</td></tr><tr><td><bold>CPAP (%)</bold></td><td>11.1</td><td>11.8</td></tr><tr><td><bold>NIV (%)</bold></td><td>6.2</td><td>7.1</td></tr><tr><td colspan="4"><bold>Respiratory support (day 10)</bold></td></tr><tr><td><bold>None (%)</bold></td><td>7.4</td><td>49.4</td><td align="char" rowspan="5">&lt; 0.0001</td></tr><tr><td><bold>LTOT (%)</bold></td><td>14.8</td><td>28.2</td></tr><tr><td><bold>HFNC (%)</bold></td><td>67.9</td><td>20.0</td></tr><tr><td><bold>CPAP (%)</bold></td><td>1.2</td><td>1.2</td></tr><tr><td><bold>NIV (%)</bold></td><td>8.6</td><td>1.2</td></tr><tr><td colspan="4"><bold>Respiratory support (day 20)</bold></td></tr><tr><td><bold>None (%)</bold></td><td>22.2</td><td>81.0</td><td align="char" rowspan="5">&lt; 0.0001</td></tr><tr><td><bold>LTOT (%)</bold></td><td>9.9</td><td>9.5</td></tr><tr><td><bold>HFNC (%)</bold></td><td>65.4</td><td>9.5</td></tr><tr><td><bold>CPAP (%)</bold></td><td>2.5</td><td>0</td></tr><tr><td><bold>NIV (%)</bold></td><td>0</td><td>0</td></tr></tbody></table></table-wrap></p>
              <p id="p0045">At 10-day evaluation, 31 % in the placebo group and 82 % in the <sc>L</sc>-Arginine group had reduced the respiratory support (
<xref rid="fig0010" ref-type="fig">Fig. 2</xref>
<bold>A</bold>). A multivariable logistic regression analysis was performed in order to examine the magnitude of association between the treatment with <sc>L</sc>-Arginine and the primary outcome: when adjusting for potential confounders including age, gender, C-reactive protein, P/F ratio, and use of monoclonal antibodies, the odds of having a reduction in respiratory support were 6.27-fold higher in those who were in the <sc>L</sc>-Arginine group compared to those in the placebo group (OR:6.27; 95 %CI: 2.08–18.87; p = 0.001). Furthermore, 20 days after randomization we detected a significant difference in the primary outcome between the two study arms (Placebo group: 5 out of 56, 9 %; <sc>L</sc>-Arginine group: 11 out of 15, 73 %; p &lt; 0.0001; <xref rid="fig0005" ref-type="fig">Fig. 1</xref>). On the contrary, changes in P/F ratio at 10 and 20 days were not significantly different (<xref rid="tbl0005" ref-type="table">Table 1</xref>).<fig id="fig0010"><label>Fig. 2</label><caption><p>Percentage of patients in which the respiratory support was reduced 10 days and 20 days after starting the therapy (<bold>A</bold>). Length of hospitalization examined in the <sc>L</sc>-Arginine and in the Placebo groups (<bold>B</bold>).</p></caption><alt-text id="at0010">Fig. 2</alt-text><graphic xlink:href="gr2_lrg"/></fig></p>
              <p id="p0050">Among the secondary outcome measures, differences between active treatment group <italic>vs</italic> placebo group were significantly different only for the time to hospital discharge, which was significantly shorter in the <sc>L</sc>-Arginine arm (22 ± 8 <italic>vs</italic> 36 ± 15 days, p &lt; 0.0001; <xref rid="fig0010" ref-type="fig">Fig. 2</xref>
<bold>B</bold>) and was confirmed in a Cox regression analysis using a fully adjusted multivariable model including age, gender, and C-reactive protein (HR:4.06; 95 %CI: 2.62–6.32; p &lt; 0.0001). The rate of lymphocyte number normalization and the time to obtain a negative RT-qPCR for SARS-CoV-2 on nasopharyngeal swab were similar between the 2 groups.</p>
              <p id="p0055">Strikingly, the evaluation of circulating cytokines revealed that <sc>L</sc>-Arginine treatment significantly reduced the pro-inflammatory IL-2, IL-6, and IFN-γ while increasing the levels of the anti-inflammatory IL-10 (
<xref rid="fig0015" ref-type="fig">Fig. 3</xref>).<fig id="fig0015"><label>Fig. 3</label><caption><p>Violin plots representing the circulating levels of IFN-γ, IL-2, IL-6, and IL-10 (<bold>A–D</bold>); *:p &lt; 0.05; **:p &lt; 0.01; ***:p &lt; 0.005; ****:p &lt; 0.001.; ns: non-significant (ANOVA and Tukey <italic>post hoc</italic> correction).</p></caption><alt-text id="at0015">Fig. 3</alt-text><graphic xlink:href="gr3_lrg"/></fig></p>
            </sec>
            <sec id="sec0040">
              <label>4</label>
              <title>Discussion</title>
              <p id="p0060">In addition to confirming in a larger population compared to the initial analysis <xref rid="bib21" ref-type="bibr">[21]</xref> the beneficial effects of <sc>L</sc>-Arginine in patients hospitalized for COVID-19, we identified in the modulation of cytokines involved in the COVID-induced inflammatory response an unprecedented mechanism underlying the favorable effects of <sc>L</sc>-Arginine in COVID-19. These results are consistent with recent metabolomics reports evidencing reduced circulating levels of <sc>L</sc>-Arginine in COVID-19 patients who experienced a severe outcome <xref rid="bib31" ref-type="bibr">[31]</xref>, <xref rid="bib32" ref-type="bibr">[32]</xref>.</p>
              <p id="p0065">Of note, the peculiar modulation of both anti- and pro- inflammatory cytokines <xref rid="bib33" ref-type="bibr">[33]</xref>, <xref rid="bib34" ref-type="bibr">[34]</xref> is remarkable and emphasizes the key role of <sc>L</sc>-Arginine metabolism in COVID-19 <xref rid="bib20" ref-type="bibr">[20]</xref>, <xref rid="bib35" ref-type="bibr">[35]</xref>, <xref rid="bib36" ref-type="bibr">[36]</xref>. Having observed that <sc>L</sc>-Arginine significantly reduces IL-6 levels is especially significant considering the recently published results of a secondary analysis of a Bayesian adaptive randomized clinical platform trial that included 4791 COVID-19 patients, showing that there was a greater than 99.9 % probability that sarilumab and tocilizumab (IL-6 receptor antagonists) improved survival through 6 months <xref rid="bib37" ref-type="bibr">[37]</xref>.</p>
              <p id="p0070">Our study is not exempt from limitations, including having measured only 4 cytokines, having enrolled exclusively patients hospitalized (which reduces the generalizability of our findings to patients with non-severe forms of COVID-19), and not having a population of patients with pulmonary disease not caused by COVID-19.</p>
              <p id="p0075">Further studies, ideally exploring more cytokines and chemokines, are warranted to dissect how exactly <sc>L</sc>-Arginine is able to modulate their circulating levels. Potential mechanisms by which <sc>L</sc>-Arginine exerts anti-inflammatory effects may include the reconstitution of circulating <sc>L</sc>-Arginine levels, a correction of nitric oxide dysfunction, and/or a direct action on immune cells <xref rid="bib38" ref-type="bibr">[38]</xref>, <xref rid="bib39" ref-type="bibr">[39]</xref>, <xref rid="bib40" ref-type="bibr">[40]</xref>, <xref rid="bib41" ref-type="bibr">[41]</xref>, <xref rid="bib42" ref-type="bibr">[42]</xref>, <xref rid="bib43" ref-type="bibr">[43]</xref>, <xref rid="bib44" ref-type="bibr">[44]</xref>, <xref rid="bib45" ref-type="bibr">[45]</xref>.</p>
              <p id="p0080">Considering that favorable effects of <sc>L</sc>-Arginine, in combination with ascorbic acid, have been recently shown also in the so-called Long-COVID <xref rid="bib36" ref-type="bibr">[36]</xref>, dedicated investigations exploring the modulation of inflammatory markers in patients with Long-COVID are needed as well.</p>
            </sec>
            <sec id="sec0045">
              <title>CRediT authorship contribution statement</title>
              <p id="p0085"><bold>Valentina Trimarco:</bold> Writing – original draft, Data curation, Formal analysis, Visualization. <bold>Raffaele Izzo:</bold> Writing – original draft, Data curation, Software. <bold>Angela Lombardi:</bold> Investigation, Visualization, Writing – review &amp; editing. <bold>Antonietta Coppola</bold>: Investigation, Data curation, Visualization. <bold>Giuseppe Fiorentino</bold>: Data curation, Visualization. <bold>Gaetano Santulli:</bold> Conceptualization, Writing – review &amp; editing.</p>
            </sec>
            <sec sec-type="data-availability" id="sec0050">
              <title>Data Availability</title>
              <p id="p0090">Data will be made available upon reasonable request to the first Author(s).</p>
            </sec>
            <sec id="sec0055">
              <title>Ethical Approval</title>
              <p id="p0095">The Study was approved by the institutional Ethical Committee of the Hospital (A.O.R.N. “Ospedali dei Colli”, Naples, Italy); written informed consent was collected from all patients, or their legal representative if they were unable to provide consent. The trial was performed in accordance with the principles of the Declaration of Helsinki and the International Conference on Harmonization-Good Clinical Practice guidelines.</p>
            </sec>
            <sec id="sec0060">
              <title>Sources of Funding</title>
              <p id="p0100">The Santulli’s Lab is supported in part by the National Institutes of Health (NIH): National Heart, Lung, and Blood Institute (<funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000050</institution-id><institution>NHLBI</institution></institution-wrap></funding-source>: R01-HL159062, R01-HL164772, R01-HL146691, T32-HL144456), National Institute of Diabetes and Digestive and Kidney Diseases (<funding-source id="gs2"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000062</institution-id><institution>NIDDK</institution></institution-wrap></funding-source>: R01-DK123259, R01-DK033823), National Center for Advancing Translational Sciences (<funding-source id="gs3"><institution-wrap><institution-id institution-id-type="doi">10.13039/100006108</institution-id><institution>NCATS</institution></institution-wrap></funding-source>: UL1TR002556-06) to G.S., by the <funding-source id="gs4"><institution-wrap><institution-id institution-id-type="doi">10.13039/100001583</institution-id><institution>Diabetes Action Research and Education Foundation</institution></institution-wrap></funding-source> (to G.S.), and by the <funding-source id="gs5">Monique Weill-Caulier and Irma T. Hirschl Trusts</funding-source> (to G.S.). This study was also supported by Grant 00014PRIN-2017 ID43237 to V.T.</p>
            </sec>
            <sec sec-type="COI-statement">
              <title>Declaration of Competing Interest</title>
              <p id="p0105">None.</p>
            </sec>
          </body>
          <back>
            <ref-list id="bibliog0005">
              <title>References</title>
              <ref id="bib1">
                <label>1</label>
                <element-citation publication-type="journal" id="sbref1">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sardu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Gambardella</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Morelli</surname>
                      <given-names>M.B.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Marfella</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence</article-title>
                  <source>J. Clin. Med.</source>
                  <volume>9</volume>
                  <issue>5</issue>
                  <year>2020</year>
                  <fpage>1417</fpage>
                  <pub-id pub-id-type="pmid">32403217</pub-id>
                </element-citation>
              </ref>
              <ref id="bib2">
                <label>2</label>
                <element-citation publication-type="journal" id="sbref2">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Trimarco</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Izzo</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Mone</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Trimarco</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Targeting endothelial dysfunction and oxidative stress in long-COVID</article-title>
                  <source>Pharm. Res.</source>
                  <volume>184</volume>
                  <year>2022</year>
                  <object-id pub-id-type="publisher-id">106451</object-id>
                </element-citation>
              </ref>
              <ref id="bib3">
                <label>3</label>
                <element-citation publication-type="journal" id="sbref3">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Trimarco</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Izzo</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Zanforlin</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Tursi</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Scarpelli</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Santus</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Pennisi</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Pelaia</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Mussi</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Mininni</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Messina</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Marazzi</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Maniscalco</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Mallardo</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Fazio</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Diana</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Capra Marzani</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Aloe</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Mone</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Trimarco</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Endothelial dysfunction in long-COVID: new insights from the nationwide multicenter LINCOLN Study</article-title>
                  <source>Pharm. Res.</source>
                  <volume>185</volume>
                  <year>2022</year>
                  <object-id pub-id-type="publisher-id">106486</object-id>
                </element-citation>
              </ref>
              <ref id="bib4">
                <label>4</label>
                <element-citation publication-type="journal" id="sbref4">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Matarese</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Gambardella</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Sardu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>miR-98 regulates TMPRSS2 expression in human endothelial cells: key implications for COVID-19</article-title>
                  <source>Biomedicines</source>
                  <volume>8</volume>
                  <issue>11</issue>
                  <year>2020</year>
                </element-citation>
              </ref>
              <ref id="bib5">
                <label>5</label>
                <element-citation publication-type="journal" id="sbref5">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Martinez-Salazar</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Holwerda</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Studle</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Piragyte</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Mercader</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Engelhardt</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Rieben</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Doring</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>COVID-19 and the vasculature: current aspects and long-term consequences</article-title>
                  <source>Front. Cell Dev. Biol.</source>
                  <volume>10</volume>
                  <year>2022</year>
                  <object-id pub-id-type="publisher-id">824851</object-id>
                </element-citation>
              </ref>
              <ref id="bib6">
                <label>6</label>
                <element-citation publication-type="journal" id="sbref6">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Castanares-Zapatero</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Chalon</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Kohn</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Dauvrin</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Detollenaere</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Maertens de Noordhout</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Primus-de Jong</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Cleemput</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Van den Heede</surname>
                      <given-names>K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Pathophysiology and mechanism of long COVID: a comprehensive review</article-title>
                  <source>Ann. Med.</source>
                  <volume>54</volume>
                  <issue>1</issue>
                  <year>2022</year>
                  <fpage>1473</fpage>
                  <lpage>1487</lpage>
                  <pub-id pub-id-type="pmid">35594336</pub-id>
                </element-citation>
              </ref>
              <ref id="bib7">
                <label>7</label>
                <element-citation publication-type="journal" id="sbref7">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ambrosino</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Calcaterra</surname>
                      <given-names>I.L.</given-names>
                    </name>
                    <name>
                      <surname>Mosella</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Formisano</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>D'Anna</surname>
                      <given-names>S.E.</given-names>
                    </name>
                    <name>
                      <surname>Bachetti</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Marcuccio</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Galloway</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Mancini</surname>
                      <given-names>F.P.</given-names>
                    </name>
                    <name>
                      <surname>Papa</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Motta</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Di Minno</surname>
                      <given-names>M.N.D.</given-names>
                    </name>
                    <name>
                      <surname>Maniscalco</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Endothelial dysfunction in COVID-19: a unifying mechanism and a potential therapeutic target</article-title>
                  <source>Biomedicines</source>
                  <volume>10</volume>
                  <issue>4</issue>
                  <year>2022</year>
                </element-citation>
              </ref>
              <ref id="bib8">
                <label>8</label>
                <element-citation publication-type="journal" id="sbref8">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Urata</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Ikeda</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Yamazaki</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Ueno</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Katayama</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Shin-Ya</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Ohgitani</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Mazda</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Matoba</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Senescent endothelial cells are predisposed to SARS-CoV-2 infection and subsequent endothelial dysfunction</article-title>
                  <source>Sci. Rep.</source>
                  <volume>12</volume>
                  <issue>1</issue>
                  <year>2022</year>
                  <fpage>11855</fpage>
                  <pub-id pub-id-type="pmid">35879338</pub-id>
                </element-citation>
              </ref>
              <ref id="bib9">
                <label>9</label>
                <element-citation publication-type="journal" id="sbref9">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kansakar</surname>
                      <given-names>U.</given-names>
                    </name>
                    <name>
                      <surname>Gambardella</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Varzideh</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Avvisato</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Jankauskas</surname>
                      <given-names>S.S.</given-names>
                    </name>
                    <name>
                      <surname>Mone</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Matarese</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>miR-142 targets TIM-1 in human endothelial cells: potential implications for stroke, COVID-19, Zika, Ebola, Dengue, and other viral infections</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <volume>23</volume>
                  <issue>18</issue>
                  <year>2022</year>
                </element-citation>
              </ref>
              <ref id="bib10">
                <label>10</label>
                <element-citation publication-type="journal" id="sbref10">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mone</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Gambardella</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Jankauskas</surname>
                      <given-names>S.S.</given-names>
                    </name>
                    <name>
                      <surname>Matarese</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>miR-24 targets the transmembrane glycoprotein neuropilin-1 in human brain microvascular endothelial cells</article-title>
                  <source>Noncoding RNA</source>
                  <volume>7</volume>
                  <issue>1</issue>
                  <year>2021</year>
                </element-citation>
              </ref>
              <ref id="bib11">
                <label>11</label>
                <element-citation publication-type="journal" id="sbref11">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Joffre</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Rodriguez</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Matthay</surname>
                      <given-names>Z.A.</given-names>
                    </name>
                    <name>
                      <surname>Lloyd</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Fields</surname>
                      <given-names>A.T.</given-names>
                    </name>
                    <name>
                      <surname>Bainton</surname>
                      <given-names>R.J.</given-names>
                    </name>
                    <name>
                      <surname>Kurien</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Sil</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Calfee</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Woodruff</surname>
                      <given-names>P.G.</given-names>
                    </name>
                    <name>
                      <surname>Erle</surname>
                      <given-names>D.J.</given-names>
                    </name>
                    <name>
                      <surname>Hendrickson</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Krummel</surname>
                      <given-names>M.F.</given-names>
                    </name>
                    <name>
                      <surname>Langelier</surname>
                      <given-names>C.R.</given-names>
                    </name>
                    <name>
                      <surname>Matthay</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Kornblith</surname>
                      <given-names>L.Z.</given-names>
                    </name>
                    <name>
                      <surname>Hellman</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Consortium</surname>
                      <given-names>C.-M.-P.f.E.T.</given-names>
                    </name>
                    <name>
                      <surname>Covid-19 Associated Coagulopathy</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Thrombosis Study</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>COVID-19-associated lung microvascular endotheliopathy: a "from the bench" perspective</article-title>
                  <source>Am. J. Respir. Crit. Care Med.</source>
                  <volume>206</volume>
                  <issue>8</issue>
                  <year>2022</year>
                  <fpage>961</fpage>
                  <lpage>972</lpage>
                  <pub-id pub-id-type="pmid">35649173</pub-id>
                </element-citation>
              </ref>
              <ref id="bib12">
                <label>12</label>
                <element-citation publication-type="journal" id="sbref12">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jankauskas</surname>
                      <given-names>S.S.</given-names>
                    </name>
                    <name>
                      <surname>Kansakar</surname>
                      <given-names>U.</given-names>
                    </name>
                    <name>
                      <surname>Sardu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Varzideh</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Avvisato</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Matarese</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Marfella</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Ziosi</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Gambardella</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>COVID-19 causes ferroptosis and oxidative stress in human endothelial cells</article-title>
                  <source>Antioxidants</source>
                  <volume>12</volume>
                  <issue>2</issue>
                  <year>2023</year>
                  <fpage>326</fpage>
                  <pub-id pub-id-type="pmid">36829885</pub-id>
                </element-citation>
              </ref>
              <ref id="bib13">
                <label>13</label>
                <element-citation publication-type="journal" id="sbref13">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gambardella</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>What is linking COVID-19 and endothelial dysfunction? Updates on nanomedicine and bioengineering from the 2020 AHA scientific sessions</article-title>
                  <source>Eur. Heart J. Cardiovasc. Pharm.</source>
                  <volume>7</volume>
                  <issue>3</issue>
                  <year>2021</year>
                  <fpage>e2</fpage>
                  <lpage>e3</lpage>
                </element-citation>
              </ref>
              <ref id="bib14">
                <label>14</label>
                <element-citation publication-type="journal" id="sbref14">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gambardella</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Coppola</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Izzo</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Fiorentino</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Trimarco</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Role of endothelial miR-24 in COVID-19 cerebrovascular events</article-title>
                  <source>Crit. Care</source>
                  <volume>25</volume>
                  <issue>1</issue>
                  <year>2021</year>
                  <fpage>306</fpage>
                  <pub-id pub-id-type="pmid">34433473</pub-id>
                </element-citation>
              </ref>
              <ref id="bib15">
                <label>15</label>
                <element-citation publication-type="journal" id="sbref15">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gambardella</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Kansakar</surname>
                      <given-names>U.</given-names>
                    </name>
                    <name>
                      <surname>Sardu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Messina</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Jankauskas</surname>
                      <given-names>S.S.</given-names>
                    </name>
                    <name>
                      <surname>Marfella</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Maggi</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Mone</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Paolisso</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Sorriento</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19</article-title>
                  <source>J. Pharm. Exp. Ther.</source>
                  <volume>384</volume>
                  <issue>1</issue>
                  <year>2023</year>
                  <fpage>109</fpage>
                  <lpage>115</lpage>
                </element-citation>
              </ref>
              <ref id="bib16">
                <label>16</label>
                <element-citation publication-type="journal" id="sbref16">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gambardella</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Khondkar</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Morelli</surname>
                      <given-names>M.B.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Trimarco</surname>
                      <given-names>V.</given-names>
                    </name>
                  </person-group>
                  <article-title>Arginine and endothelial function</article-title>
                  <source>Biomedicines</source>
                  <volume>8</volume>
                  <issue>8</issue>
                  <year>2020</year>
                </element-citation>
              </ref>
              <ref id="bib17">
                <label>17</label>
                <element-citation publication-type="journal" id="sbref17">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Monti</surname>
                      <given-names>L.D.</given-names>
                    </name>
                    <name>
                      <surname>Casiraghi</surname>
                      <given-names>M.C.</given-names>
                    </name>
                    <name>
                      <surname>Setola</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Galluccio</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Pagani</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Quaglia</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Bosi</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Piatti</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title><sc>L</sc>-arginine enriched biscuits improve endothelial function and glucose metabolism: a pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome</article-title>
                  <source>Metabolism</source>
                  <volume>62</volume>
                  <issue>2</issue>
                  <year>2013</year>
                  <fpage>255</fpage>
                  <lpage>264</lpage>
                  <pub-id pub-id-type="pmid">23040413</pub-id>
                </element-citation>
              </ref>
              <ref id="bib18">
                <label>18</label>
                <element-citation publication-type="journal" id="sbref18">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mammedova</surname>
                      <given-names>J.T.</given-names>
                    </name>
                    <name>
                      <surname>Sokolov</surname>
                      <given-names>A.V.</given-names>
                    </name>
                    <name>
                      <surname>Freidlin</surname>
                      <given-names>I.S.</given-names>
                    </name>
                    <name>
                      <surname>Starikova</surname>
                      <given-names>E.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>The mechanisms of <sc>L</sc>-arginine metabolism disorder in endothelial cells</article-title>
                  <source>Biochemistry</source>
                  <volume>86</volume>
                  <issue>2</issue>
                  <year>2021</year>
                  <fpage>146</fpage>
                  <lpage>155</lpage>
                  <pub-id pub-id-type="pmid">33832413</pub-id>
                </element-citation>
              </ref>
              <ref id="bib19">
                <label>19</label>
                <element-citation publication-type="journal" id="sbref19">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Melik</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Zaletel</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Virtic</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Cankar</surname>
                      <given-names>K.</given-names>
                    </name>
                  </person-group>
                  <article-title><sc>L</sc>-arginine as dietary supplement for improving microvascular function</article-title>
                  <source>Clin. Hemorheol. Microcirc.</source>
                  <volume>65</volume>
                  <issue>3</issue>
                  <year>2017</year>
                  <fpage>205</fpage>
                  <lpage>217</lpage>
                  <pub-id pub-id-type="pmid">27814280</pub-id>
                </element-citation>
              </ref>
              <ref id="bib20">
                <label>20</label>
                <element-citation publication-type="journal" id="sbref20">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Adebayo</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Varzideh</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Wilson</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Gambardella</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Eacobacci</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Jankauskas</surname>
                      <given-names>S.S.</given-names>
                    </name>
                    <name>
                      <surname>Donkor</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Kansakar</surname>
                      <given-names>U.</given-names>
                    </name>
                    <name>
                      <surname>Trimarco</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Mone</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Lombardi</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title><sc>l</sc>-arginine and COVID-19: an update</article-title>
                  <source>Nutrients</source>
                  <volume>13</volume>
                  <issue>11</issue>
                  <year>2021</year>
                </element-citation>
              </ref>
              <ref id="bib21">
                <label>21</label>
                <element-citation publication-type="journal" id="sbref21">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fiorentino</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Coppola</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Izzo</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Annunziata</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Bernardo</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Lombardi</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Trimarco</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Trimarco</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of adding <sc>L</sc>-arginine orally to standard therapy in patients with COVID-19: a randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis</article-title>
                  <source>EClinicalMedicine</source>
                  <volume>40</volume>
                  <year>2021</year>
                  <object-id pub-id-type="publisher-id">101125</object-id>
                </element-citation>
              </ref>
              <ref id="bib22">
                <label>22</label>
                <element-citation publication-type="journal" id="sbref22">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Geiger</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Rieckmann</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>Wolf</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Basso</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Feng</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Fuhrer</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Kogadeeva</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Picotti</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Meissner</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Zamboni</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Sallusto</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Lanzavecchia</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title><sc>L</sc>-arginine modulates T cell metabolism and enhances survival and anti-tumor activity</article-title>
                  <source>Cell</source>
                  <volume>167</volume>
                  <issue>3</issue>
                  <year>2016</year>
                  <fpage>829</fpage>
                  <lpage>842</lpage>
                  <comment>(e13)</comment>
                  <pub-id pub-id-type="pmid">27745970</pub-id>
                </element-citation>
              </ref>
              <ref id="bib23">
                <label>23</label>
                <element-citation publication-type="journal" id="sbref23">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Qiu</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Gao</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Jiang</surname>
                      <given-names>Z.</given-names>
                    </name>
                  </person-group>
                  <article-title><sc>L</sc>-arginine inhibited inflammatory response and oxidative stress induced by lipopolysaccharide via arginase-1 signaling in IPEC-J2 cells</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <volume>20</volume>
                  <issue>7</issue>
                  <year>2019</year>
                </element-citation>
              </ref>
              <ref id="bib24">
                <label>24</label>
                <element-citation publication-type="journal" id="sbref24">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hnia</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Gayraud</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Hugon</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Ramonatxo</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>De La Porte</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Matecki</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Mornet</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title><sc>L</sc>-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers</article-title>
                  <source>Am. J. Pathol.</source>
                  <volume>172</volume>
                  <issue>6</issue>
                  <year>2008</year>
                  <fpage>1509</fpage>
                  <lpage>1519</lpage>
                  <pub-id pub-id-type="pmid">18458097</pub-id>
                </element-citation>
              </ref>
              <ref id="bib25">
                <label>25</label>
                <element-citation publication-type="journal" id="sbref25">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Raghavan</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Dikshit</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Vascular regulation by the <sc>L</sc>-arginine metabolites, nitric oxide and agmatine</article-title>
                  <source>Pharm. Res.</source>
                  <volume>49</volume>
                  <issue>5</issue>
                  <year>2004</year>
                  <fpage>397</fpage>
                  <lpage>414</lpage>
                </element-citation>
              </ref>
              <ref id="bib26">
                <label>26</label>
                <element-citation publication-type="journal" id="sbref26">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yang</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Xie</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Tu</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Fu</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>The signal pathways and treatment of cytokine storm in COVID-19</article-title>
                  <source>Signal. Transduct. Target Ther.</source>
                  <volume>6</volume>
                  <issue>1</issue>
                  <year>2021</year>
                  <fpage>255</fpage>
                  <pub-id pub-id-type="pmid">34234112</pub-id>
                </element-citation>
              </ref>
              <ref id="bib27">
                <label>27</label>
                <element-citation publication-type="journal" id="sbref27">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dhar</surname>
                      <given-names>S.K.</given-names>
                    </name>
                    <name>
                      <surname>K</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Damodar</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Gujar</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Das</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression</article-title>
                  <source>Heliyon</source>
                  <volume>7</volume>
                  <issue>2</issue>
                  <year>2021</year>
                  <object-id pub-id-type="publisher-id">e06155</object-id>
                </element-citation>
              </ref>
              <ref id="bib28">
                <label>28</label>
                <element-citation publication-type="journal" id="sbref28">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gordon</surname>
                      <given-names>A.C.</given-names>
                    </name>
                    <name>
                      <surname>Mouncey</surname>
                      <given-names>P.R.</given-names>
                    </name>
                    <name>
                      <surname>Al-Beidh</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Rowan</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Nichol</surname>
                      <given-names>A.D.</given-names>
                    </name>
                    <name>
                      <surname>Arabi</surname>
                      <given-names>Y.M.</given-names>
                    </name>
                    <name>
                      <surname>Annane</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Beane</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>van Bentum-Puijk</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Berry</surname>
                      <given-names>L.R.</given-names>
                    </name>
                    <name>
                      <surname>Bhimani</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Bonten</surname>
                      <given-names>M.J.M.</given-names>
                    </name>
                    <name>
                      <surname>Bradbury</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>Brunkhorst</surname>
                      <given-names>F.M.</given-names>
                    </name>
                    <name>
                      <surname>Buzgau</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>A.C.</given-names>
                    </name>
                    <name>
                      <surname>Detry</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Duffy</surname>
                      <given-names>E.J.</given-names>
                    </name>
                    <name>
                      <surname>Estcourt</surname>
                      <given-names>L.J.</given-names>
                    </name>
                    <name>
                      <surname>Fitzgerald</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Goossens</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Haniffa</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Higgins</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Hills</surname>
                      <given-names>T.E.</given-names>
                    </name>
                    <name>
                      <surname>Horvat</surname>
                      <given-names>C.M.</given-names>
                    </name>
                    <name>
                      <surname>Lamontagne</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Lawler</surname>
                      <given-names>P.R.</given-names>
                    </name>
                    <name>
                      <surname>Leavis</surname>
                      <given-names>H.L.</given-names>
                    </name>
                    <name>
                      <surname>Linstrum</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Litton</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Lorenzi</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Marshall</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>Mayr</surname>
                      <given-names>F.B.</given-names>
                    </name>
                    <name>
                      <surname>McAuley</surname>
                      <given-names>D.F.</given-names>
                    </name>
                    <name>
                      <surname>McGlothlin</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>McGuinness</surname>
                      <given-names>S.P.</given-names>
                    </name>
                    <name>
                      <surname>McVerry</surname>
                      <given-names>B.J.</given-names>
                    </name>
                    <name>
                      <surname>Montgomery</surname>
                      <given-names>S.K.</given-names>
                    </name>
                    <name>
                      <surname>Morpeth</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Murthy</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Orr</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Parke</surname>
                      <given-names>R.L.</given-names>
                    </name>
                    <name>
                      <surname>Parker</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>Patanwala</surname>
                      <given-names>A.E.</given-names>
                    </name>
                    <name>
                      <surname>Pettila</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Rademaker</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>M.S.</given-names>
                    </name>
                    <name>
                      <surname>Saunders</surname>
                      <given-names>C.T.</given-names>
                    </name>
                    <name>
                      <surname>Seymour</surname>
                      <given-names>C.W.</given-names>
                    </name>
                    <name>
                      <surname>Shankar-Hari</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Sligl</surname>
                      <given-names>W.I.</given-names>
                    </name>
                    <name>
                      <surname>Turgeon</surname>
                      <given-names>A.F.</given-names>
                    </name>
                    <name>
                      <surname>Turner</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>van de Veerdonk</surname>
                      <given-names>F.L.</given-names>
                    </name>
                    <name>
                      <surname>Zarychanski</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Green</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Lewis</surname>
                      <given-names>R.J.</given-names>
                    </name>
                    <name>
                      <surname>Angus</surname>
                      <given-names>D.C.</given-names>
                    </name>
                    <name>
                      <surname>McArthur</surname>
                      <given-names>C.J.</given-names>
                    </name>
                    <name>
                      <surname>Berry</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Webb</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Derde</surname>
                      <given-names>L.P.G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Interleukin-6 receptor antagonists in critically Ill patients with covid-19</article-title>
                  <source>N. Engl. J. Med.</source>
                  <volume>384</volume>
                  <issue>16</issue>
                  <year>2021</year>
                  <fpage>1491</fpage>
                  <lpage>1502</lpage>
                  <pub-id pub-id-type="pmid">33631065</pub-id>
                </element-citation>
              </ref>
              <ref id="bib29">
                <label>29</label>
                <element-citation publication-type="journal" id="sbref29">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gadotti</surname>
                      <given-names>A.C.</given-names>
                    </name>
                    <name>
                      <surname>de Castro Deus</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Telles</surname>
                      <given-names>J.P.</given-names>
                    </name>
                    <name>
                      <surname>Wind</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Goes</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Garcia Charello Ossoski</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>de Padua</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>de Noronha</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Moreno-Amaral</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Baena</surname>
                      <given-names>C.P.</given-names>
                    </name>
                    <name>
                      <surname>Tuon</surname>
                      <given-names>F.F.</given-names>
                    </name>
                  </person-group>
                  <article-title>IFN-gamma is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection</article-title>
                  <source>Virus Res.</source>
                  <volume>289</volume>
                  <year>2020</year>
                  <object-id pub-id-type="publisher-id">198171</object-id>
                </element-citation>
              </ref>
              <ref id="bib30">
                <label>30</label>
                <element-citation publication-type="journal" id="sbref30">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Merad</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Blish</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>Sallusto</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Iwasaki</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>The immunology and immunopathology of COVID-19</article-title>
                  <source>Science</source>
                  <volume>375</volume>
                  <issue>6585</issue>
                  <year>2022</year>
                  <fpage>1122</fpage>
                  <lpage>1127</lpage>
                  <pub-id pub-id-type="pmid">35271343</pub-id>
                </element-citation>
              </ref>
              <ref id="bib31">
                <label>31</label>
                <element-citation publication-type="journal" id="sbref31">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rees</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>Rostad</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>Mantus</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Anderson</surname>
                      <given-names>E.J.</given-names>
                    </name>
                    <name>
                      <surname>Chahroudi</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Jaggi</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Wrammert</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Ochoa</surname>
                      <given-names>J.B.</given-names>
                    </name>
                    <name>
                      <surname>Ochoa</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Basu</surname>
                      <given-names>R.K.</given-names>
                    </name>
                    <name>
                      <surname>Heilman</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Harris</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Lapp</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Hussaini</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Vos</surname>
                      <given-names>M.B.</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>L.A.</given-names>
                    </name>
                    <name>
                      <surname>Morris</surname>
                      <given-names>C.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Altered amino acid profile in patients with SARS-CoV-2 infection</article-title>
                  <source>Proc. Natl. Acad. Sci. USA</source>
                  <volume>118</volume>
                  <issue>25</issue>
                  <year>2021</year>
                </element-citation>
              </ref>
              <ref id="bib32">
                <label>32</label>
                <element-citation publication-type="journal" id="sbref32">
                  <person-group person-group-type="author">
                    <name>
                      <surname>D'Alessandro</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Thomas</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Akpan</surname>
                      <given-names>I.J.</given-names>
                    </name>
                    <name>
                      <surname>Reisz</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Cendali</surname>
                      <given-names>F.I.</given-names>
                    </name>
                    <name>
                      <surname>Gamboni</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Nemkov</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Thangaraju</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Katneni</surname>
                      <given-names>U.</given-names>
                    </name>
                    <name>
                      <surname>Tanaka</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Kahn</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Wei</surname>
                      <given-names>A.Z.</given-names>
                    </name>
                    <name>
                      <surname>Valk</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Hudson</surname>
                      <given-names>K.E.</given-names>
                    </name>
                    <name>
                      <surname>Roh</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Moriconi</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Zimring</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>Hod</surname>
                      <given-names>E.A.</given-names>
                    </name>
                    <name>
                      <surname>Spitalnik</surname>
                      <given-names>S.L.</given-names>
                    </name>
                    <name>
                      <surname>Buehler</surname>
                      <given-names>P.W.</given-names>
                    </name>
                    <name>
                      <surname>Francis</surname>
                      <given-names>R.O.</given-names>
                    </name>
                  </person-group>
                  <article-title>Biological and clinical factors contributing to the metabolic heterogeneity of hospitalized patients with and without COVID-19</article-title>
                  <source>Cells</source>
                  <volume>10</volume>
                  <issue>9</issue>
                  <year>2021</year>
                  <fpage>2293</fpage>
                  <pub-id pub-id-type="pmid">34571942</pub-id>
                </element-citation>
              </ref>
              <ref id="bib33">
                <label>33</label>
                <element-citation publication-type="journal" id="sbref33">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Perlman</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>COVID-19: inflammatory profile</article-title>
                  <source>Annu. Rev. Med.</source>
                  <volume>73</volume>
                  <year>2022</year>
                  <fpage>65</fpage>
                  <lpage>80</lpage>
                  <pub-id pub-id-type="pmid">34437814</pub-id>
                </element-citation>
              </ref>
              <ref id="bib34">
                <label>34</label>
                <element-citation publication-type="journal" id="sbref34">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tang</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Yin</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Hu</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Mei</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Controlling cytokine storm is vital in COVID-19</article-title>
                  <source>Front. Immunol.</source>
                  <volume>11</volume>
                  <year>2020</year>
                  <object-id pub-id-type="publisher-id">570993</object-id>
                </element-citation>
              </ref>
              <ref id="bib35">
                <label>35</label>
                <element-citation publication-type="journal" id="sbref35">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mone</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Izzo</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Marazzi</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Manzi</surname>
                      <given-names>M.V.</given-names>
                    </name>
                    <name>
                      <surname>Gallo</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Campolongo</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Cacciotti</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Tartaglia</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Caminiti</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Varzideh</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Trimarco</surname>
                      <given-names>V.</given-names>
                    </name>
                  </person-group>
                  <article-title><sc>L</sc>-arginine enhances the effects of cardiac rehabilitation on physical performance: new insights for managing cardiovascular patients during the COVID-19 pandemic</article-title>
                  <source>J. Pharm. Exp. Ther.</source>
                  <volume>381</volume>
                  <issue>3</issue>
                  <year>2022</year>
                  <fpage>197</fpage>
                  <lpage>203</lpage>
                </element-citation>
              </ref>
              <ref id="bib36">
                <label>36</label>
                <element-citation publication-type="journal" id="sbref36">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Izzo</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Trimarco</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Mone</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Aloe</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Capra Marzani</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Diana</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Fazio</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Mallardo</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Maniscalco</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Marazzi</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Messina</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Mininni</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Mussi</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Pelaia</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Pennisi</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Santus</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Scarpelli</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Tursi</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Zanforlin</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Santulli</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Trimarco</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Combining <sc>L</sc>-arginine with vitamin C improves long-COVID symptoms: the LINCOLN survey</article-title>
                  <source>Pharm. Res.</source>
                  <volume>183</volume>
                  <year>2022</year>
                  <object-id pub-id-type="publisher-id">106360</object-id>
                </element-citation>
              </ref>
              <ref id="bib37">
                <label>37</label>
                <element-citation publication-type="journal" id="sbref37">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Higgins</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Berry</surname>
                      <given-names>L.R.</given-names>
                    </name>
                    <name>
                      <surname>Lorenzi</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Murthy</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>McQuilten</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Mouncey</surname>
                      <given-names>P.R.</given-names>
                    </name>
                    <name>
                      <surname>Al-Beidh</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Annane</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Arabi</surname>
                      <given-names>Y.M.</given-names>
                    </name>
                    <name>
                      <surname>Beane</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>van Bentum-Puijk</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Bhimani</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Bonten</surname>
                      <given-names>M.J.M.</given-names>
                    </name>
                    <name>
                      <surname>Bradbury</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>Brunkhorst</surname>
                      <given-names>F.M.</given-names>
                    </name>
                    <name>
                      <surname>Burrell</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Buzgau</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Buxton</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Charles</surname>
                      <given-names>W.N.</given-names>
                    </name>
                    <name>
                      <surname>Cove</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Detry</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Estcourt</surname>
                      <given-names>L.J.</given-names>
                    </name>
                    <name>
                      <surname>Fagbodun</surname>
                      <given-names>E.O.</given-names>
                    </name>
                    <name>
                      <surname>Fitzgerald</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Girard</surname>
                      <given-names>T.D.</given-names>
                    </name>
                    <name>
                      <surname>Goligher</surname>
                      <given-names>E.C.</given-names>
                    </name>
                    <name>
                      <surname>Goossens</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Haniffa</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Hills</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Horvat</surname>
                      <given-names>C.M.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>D.T.</given-names>
                    </name>
                    <name>
                      <surname>Ichihara</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Lamontagne</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Marshall</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>McAuley</surname>
                      <given-names>D.F.</given-names>
                    </name>
                    <name>
                      <surname>McGlothlin</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>McGuinness</surname>
                      <given-names>S.P.</given-names>
                    </name>
                    <name>
                      <surname>McVerry</surname>
                      <given-names>B.J.</given-names>
                    </name>
                    <name>
                      <surname>Neal</surname>
                      <given-names>M.D.</given-names>
                    </name>
                    <name>
                      <surname>Nichol</surname>
                      <given-names>A.D.</given-names>
                    </name>
                    <name>
                      <surname>Parke</surname>
                      <given-names>R.L.</given-names>
                    </name>
                    <name>
                      <surname>Parker</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>Parry-Billings</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Peters</surname>
                      <given-names>S.E.C.</given-names>
                    </name>
                    <name>
                      <surname>Reyes</surname>
                      <given-names>L.F.</given-names>
                    </name>
                    <name>
                      <surname>Rowan</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Saito</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>M.S.</given-names>
                    </name>
                    <name>
                      <surname>Saunders</surname>
                      <given-names>C.T.</given-names>
                    </name>
                    <name>
                      <surname>Serpa-Neto</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Seymour</surname>
                      <given-names>C.W.</given-names>
                    </name>
                    <name>
                      <surname>Shankar-Hari</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Stronach</surname>
                      <given-names>L.M.</given-names>
                    </name>
                    <name>
                      <surname>Turgeon</surname>
                      <given-names>A.F.</given-names>
                    </name>
                    <name>
                      <surname>Turner</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>van de Veerdonk</surname>
                      <given-names>F.L.</given-names>
                    </name>
                    <name>
                      <surname>Zarychanski</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Green</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Lewis</surname>
                      <given-names>R.J.</given-names>
                    </name>
                    <name>
                      <surname>Angus</surname>
                      <given-names>D.C.</given-names>
                    </name>
                    <name>
                      <surname>McArthur</surname>
                      <given-names>C.J.</given-names>
                    </name>
                    <name>
                      <surname>Berry</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Derde</surname>
                      <given-names>L.P.G.</given-names>
                    </name>
                    <name>
                      <surname>Gordon</surname>
                      <given-names>A.C.</given-names>
                    </name>
                    <name>
                      <surname>Webb</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Lawler</surname>
                      <given-names>P.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Long-term (180-day) outcomes in critically Ill patients with COVID-19 in the REMAP-CAP randomized clinical trial</article-title>
                  <source>JAMA</source>
                  <volume>329</volume>
                  <issue>1</issue>
                  <year>2023</year>
                  <fpage>39</fpage>
                  <lpage>51</lpage>
                  <pub-id pub-id-type="pmid">36525245</pub-id>
                </element-citation>
              </ref>
              <ref id="bib38">
                <label>38</label>
                <element-citation publication-type="journal" id="sbref38">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Crowther</surname>
                      <given-names>R.R.</given-names>
                    </name>
                    <name>
                      <surname>Schmidt</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Lange</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>McKell</surname>
                      <given-names>M.C.</given-names>
                    </name>
                    <name>
                      <surname>Robillard</surname>
                      <given-names>M.C.</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Haffey</surname>
                      <given-names>W.D.</given-names>
                    </name>
                    <name>
                      <surname>Wyder</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Greis</surname>
                      <given-names>K.D.</given-names>
                    </name>
                    <name>
                      <surname>Setchell</surname>
                      <given-names>K.D.R.</given-names>
                    </name>
                    <name>
                      <surname>Qualls</surname>
                      <given-names>J.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cutting edge: <sc>l</sc>-arginine transfer from antigen-presenting cells sustains CD4(+) T cell viability and proliferation</article-title>
                  <source>J. Immunol.</source>
                  <volume>208</volume>
                  <issue>4</issue>
                  <year>2022</year>
                  <fpage>793</fpage>
                  <lpage>798</lpage>
                  <pub-id pub-id-type="pmid">35101895</pub-id>
                </element-citation>
              </ref>
              <ref id="bib39">
                <label>39</label>
                <element-citation publication-type="journal" id="sbref39">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grzywa</surname>
                      <given-names>T.M.</given-names>
                    </name>
                    <name>
                      <surname>Sosnowska</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Matryba</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Rydzynska</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Jasinski</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Nowis</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Golab</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Myeloid cell-derived arginase in cancer immune response</article-title>
                  <source>Front. Immunol.</source>
                  <volume>11</volume>
                  <year>2020</year>
                  <fpage>938</fpage>
                  <pub-id pub-id-type="pmid">32499785</pub-id>
                </element-citation>
              </ref>
              <ref id="bib40">
                <label>40</label>
                <element-citation publication-type="journal" id="sbref40">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>Y.C.</given-names>
                    </name>
                    <name>
                      <surname>Su</surname>
                      <given-names>Y.T.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>T.Y.</given-names>
                    </name>
                    <name>
                      <surname>Tsai</surname>
                      <given-names>C.M.</given-names>
                    </name>
                    <name>
                      <surname>Chang</surname>
                      <given-names>C.H.</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>H.R.</given-names>
                    </name>
                  </person-group>
                  <article-title><sc>L</sc>-arginine and <sc>l</sc>-citrulline supplementation have different programming effect on regulatory T-cells function of infantile rats</article-title>
                  <source>Front. Immunol.</source>
                  <volume>9</volume>
                  <year>2018</year>
                  <fpage>2911</fpage>
                  <pub-id pub-id-type="pmid">30619275</pub-id>
                </element-citation>
              </ref>
              <ref id="bib41">
                <label>41</label>
                <element-citation publication-type="journal" id="sbref41">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bronte</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Serafini</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Mazzoni</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Segal</surname>
                      <given-names>D.M.</given-names>
                    </name>
                    <name>
                      <surname>Zanovello</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title><sc>L</sc>-arginine metabolism in myeloid cells controls T-lymphocyte functions</article-title>
                  <source>Trends Immunol.</source>
                  <volume>24</volume>
                  <issue>6</issue>
                  <year>2003</year>
                  <fpage>302</fpage>
                  <lpage>306</lpage>
                  <pub-id pub-id-type="pmid">12810105</pub-id>
                </element-citation>
              </ref>
              <ref id="bib42">
                <label>42</label>
                <element-citation publication-type="journal" id="sbref42">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cao</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Du</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Feng</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Jin</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title><sc>l</sc>-arginine and docetaxel synergistically enhance anti-tumor immunity by modifying the immune status of tumor-bearing mice</article-title>
                  <source>Int. Immunopharmacol.</source>
                  <volume>35</volume>
                  <year>2016</year>
                  <fpage>7</fpage>
                  <lpage>14</lpage>
                  <pub-id pub-id-type="pmid">27003114</pub-id>
                </element-citation>
              </ref>
              <ref id="bib43">
                <label>43</label>
                <element-citation publication-type="journal" id="sbref43">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bronte</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Zanovello</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Regulation of immune responses by <sc>L</sc>-arginine metabolism</article-title>
                  <source>Nat. Rev. Immunol.</source>
                  <volume>5</volume>
                  <issue>8</issue>
                  <year>2005</year>
                  <fpage>641</fpage>
                  <lpage>654</lpage>
                  <pub-id pub-id-type="pmid">16056256</pub-id>
                </element-citation>
              </ref>
              <ref id="bib44">
                <label>44</label>
                <element-citation publication-type="journal" id="sbref44">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yu</surname>
                      <given-names>H.R.</given-names>
                    </name>
                    <name>
                      <surname>Hsu</surname>
                      <given-names>T.Y.</given-names>
                    </name>
                    <name>
                      <surname>Tsai</surname>
                      <given-names>C.C.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>H.C.</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>H.H.</given-names>
                    </name>
                    <name>
                      <surname>Lai</surname>
                      <given-names>Y.J.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>Y.J.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>C.C.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>K.</given-names>
                    </name>
                  </person-group>
                  <article-title>The functional DNA methylation signatures relevant to altered immune response of neonatal T cells with <sc>l</sc>-arginine supplementation</article-title>
                  <source>Nutrients</source>
                  <volume>13</volume>
                  <issue>8</issue>
                  <year>2021</year>
                </element-citation>
              </ref>
              <ref id="bib45">
                <label>45</label>
                <element-citation publication-type="journal" id="sbref45">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Guo</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Jiang</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Qin</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Luo</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Du</surname>
                      <given-names>Y.Z.</given-names>
                    </name>
                    <name>
                      <surname>Luo</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>You</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Arginine supplementation targeting tumor-killing immune cells reconstructs the tumor microenvironment and enhances the antitumor immune response</article-title>
                  <source>ACS Nano</source>
                  <volume>16</volume>
                  <issue>8</issue>
                  <year>2022</year>
                  <fpage>12964</fpage>
                  <lpage>12978</lpage>
                  <pub-id pub-id-type="pmid">35968927</pub-id>
                </element-citation>
              </ref>
            </ref-list>
            <ack id="ack0005">
              <title>Acknowledgement</title>
              <p id="p0110">We thank Drs. Wang and Gambardella for helpful discussion.</p>
            </ack>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
